TMCnet News

Research and Markets: Gastrointestinal Radiation Toxicity Pipeline Review, H1 2015 - 3 Companies & 5 Drug Profiles
[June 08, 2015]

Research and Markets: Gastrointestinal Radiation Toxicity Pipeline Review, H1 2015 - 3 Companies & 5 Drug Profiles


Research and Markets (http://www.researchandmarkets.com/research/j3jsq3/gastrointestinal) has announced the addition of the "Gastrointestinal Radiation Toxicity - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Gastrointestinal Radiation Toxicity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along withlatest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastrointestinal Radiation Toxicity and special features on late-stage and discontinued projects.



The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development


  • Aeolus Pharmaceuticals, Inc.
  • Avaxia Biologics, Inc.
  • Soligenix, Inc.

Drug Profiles

  • 2A2
  • AEOL-10150
  • AVX (News - Alert)-470
  • m2A2
  • SGX-202

For more information visit http://www.researchandmarkets.com/research/j3jsq3/gastrointestinal


[ Back To TMCnet.com's Homepage ]